Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Herbert J. Zeh"'
Autor:
Nathan Bahary, Mazen S. Zenati, M.E. Hogg, Asmita Chopra, Herbert J. Zeh, David L. Bartlett, Joal D. Beane, Amer H. Zureikat
Publikováno v:
Annals of Surgical Oncology. 28:7759-7769
A positive microscopic margin (R1) following resection of pancreatic ductal adenocarcinoma (PDAC) can occur in up to 80% of patients and is associated with reduced survival and increased recurrence. Our aim was to characterize the impact of neoadjuva
Autor:
Patricio M. Polanco, John D. Karalis, Herbert J. Zeh, James Michael Blackwell, Matthew R. Porembka, Michelle R. Ju, Adam C. Yopp, John C. Mansour, Mathew M. Augustine, Sam C. Wang
Publikováno v:
Annals of Surgical Oncology. 28:2831-2843
Accurate clinical staging (CS) of gastric cancer is critical for appropriate treatment selection and prognostication, but CS remains highly imprecise. Our study evaluates factors associated with inaccurate CS, the impact of inaccurate CS on outcomes,
Autor:
Brian A. Boone, Kelsey A. Musgrove, Carl Schmidt, Alan A Thomay, Pavan Rao, Britney R. Harris, Melissa E. Hogg, Herbert J. Zeh, Amer H. Zureikat, J. Wallis Marsh
Publikováno v:
J Surg Oncol
Introduction The learning curve associated with robotic pancreatoduodenectomy (RPD) is a hurdle for new programs to achieve optimal results. Since early analysis, robotic training has recently expanded, and the RPD approach has been refined. The purp
Autor:
Melissa E. Hogg, Jeffrey D. Borrebach, Amer H. Zureikat, Johanna E. Bellon, Henry A. Pitt, Herbert J. Zeh, Amr I. Al Abbas
Publikováno v:
Journal of Gastrointestinal Surgery. 25:1503-1511
Pancreatoduodenectomy (PD) is often performed in frail patients and is associated with significant morbidity. The five-factor modified frailty index (mFI-5) has been utilized to predict adverse postoperative outcomes, but has not been tested in PD. W
Autor:
Jae Pil Jung, Alessandro Paniccia, Mazen S. Zenati, Herbert J. Zeh, Kenneth K.W. Lee, Nathan Bahary, Melissa E. Hogg, Ana Gleisner, Amr I. Al Abbas, David L. Bartlett, Amer H. Zureikat
Publikováno v:
Annals of Surgical Oncology. 27:2961-2971
Neoadjuvant therapy (NT) is a growing strategy in localized head pancreatic adenocarcinoma (PDC). However, a significant portion of NT patients do not reach resection due to disease progression or performance status decline. We sought to identify pre
Autor:
Mazen S. Zenati, Amer H. Zureikat, Melissa E. Hogg, Amr I. Al Abbas, Herbert J. Zeh, Jae Pil Jung, Caroline J. Reiser, Ahmad Hamad
Publikováno v:
Ann Surg Oncol
INTRODUCTION: Optimal cut-offs for CA19-9 response after neoadjuvant therapy (NT) for pancreatic adenocarcinoma (PDAC) are not well characterized. This study aims to analyze the relationship of serum CA19-9 with other markers of response and identify
Autor:
Melissa E. Hogg, Amir A. Borhani, Herbert J. Zeh, Juliana Tobler, Ahmad Hamad, Mazen S. Zenati, Amer H. Zureikat, Patrick R. Varley, A. Klobuka
Publikováno v:
HPB. 21:695-701
We sought to investigate whether robotic pancreatoduodenectomy (RPD) mitigates adverse outcomes in patients with high-risk morphometric features compared to the open approach (OPD).Morphometric parameters for RPD and OPDs were measured by two blinded
Autor:
Deepa Magge, Amer H. Zureikat, Ahmad Hamad, Mazen S. Zenati, Herbert J. Zeh, Melissa E. Hogg, Caroline J. Rieser
Publikováno v:
HPB. 20:1172-1180
NSQIP data show that half of distal pancreatectomies (DP) are performed by a minimally invasive approach (MIS). Advantages have been demonstrated for MIS DP, yet comparative cost data are limited. Outcomes and cost were compared in patients undergoin
Autor:
Herbert J. Zeh, Hiroki Yamaue, Matthew J. Weiss, Roberto Salvia, Thilo Hackert, Ugo Boggi, Marc G. Besselink, Sjors Klompmaker
Publikováno v:
Journal of Gastrointestinal Surgery
Journal of gastrointestinal surgery, 22(10), 1804-1810. Springer New York
Journal of gastrointestinal surgery, 22(10), 1804-1810. Springer New York
Approximately 30% of all pancreatic cancer patients have locally advanced (AJCC stage 3) disease. A sub-group of these patients—where the cancer only involves the celiac axis—may benefit from distal pancreatectomy with celiac axis resection (DP-C
Autor:
Mazen S. Zenati, Herbert J. Zeh, Brian A. Boone, Amr Al-abbas, Melissa E. Hogg, Jillian Bonaroti, Caroline J. Rieser, Amer H. Zureikat
Publikováno v:
HPB (Oxford)
Background The short-term morbidity associated with post-operative pancreatic fistula (POPF) is well established, however data regarding the long-term impact are lacking. We aim to characterize long-term oncologic outcomes of POPF after pancreatic re